Philip Gutry appointed as Chief Business Officer by Kronos Bio

World |  News | 0 Comment | 28 Nov, 2018

U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...Read more

Merck Foundation underscores partnership with Health ministry of C.A.R.

World |  News | 0 Comment | 28 Nov, 2018

Merck Foundation, the philanthropic arm of Merck Germany underscored their commitment to build healthcare capacity in th...Read more

Aspen launches novel HIV drug combination

World |  News | 0 Comment | 28 Nov, 2018

Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of E...Read more

Axovant strengthens team to support gene therapy pipeline

World |  News | 0 Comment | 27 Nov, 2018

Clinical-stage gene therapy company Axovant has announced the addition of five senior team members to strengthen its exp...Read more

DRC initiates first-ever multi-drug Ebola trial

World |  News | 0 Comment | 27 Nov, 2018

First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...Read more

REGENXBIO, Rocket Pharma partner for Danon disease

World |  News | 0 Comment | 26 Nov, 2018

REGENXBIO Inc, a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of...Read more

Cobra, Pall, Cell and Gene Therapy Catapult win £1.5M Innovate UK grant

World |  News | 0 Comment | 26 Nov, 2018

Singapore –Cobra Biologics, an international contract development and manufacturing organization (CDMO) ...Read more

Santhera to acquire exclusive sub-license of Vamorolone

World |  News | 0 Comment | 26 Nov, 2018

Santhera Pharmaceuticals which is Swiss specialty pharmaceutical company focused on the development and commercializatio...Read more

Altus Capital acquires ChoiceSpine

World |  News | 0 Comment | 26 Nov, 2018

An investment firm focused on the North American manufacturing sector, Altus Capital Partners has announced that it has ...Read more

Eurofins to distribute Synthego's Genome Engineering products

World |  News | 0 Comment | 23 Nov, 2018

Synthego, the leading provider of genome engineering products, and Eurofins Genomics, a global leader in bioanalytical t...Read more

Mylan recalls batches of blood-pressure drug containing valsartan

World |  News | 0 Comment | 22 Nov, 2018

Singapore - Mylan N.V. announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide...Read more

Eureka Therapeutics publicizes preclinical study validating ARTEMIS Platform

World |  News | 0 Comment | 22 Nov, 2018

Eureka Therapeutics has announced publication in Cell Discovery validating its ARTEMIS antibody-TCR (AbTC...Read more

Brickell Biotech appoints Robert Brown as CEO

World |  News | 0 Comment | 21 Nov, 2018

Notable leadership change comes as Brickell prepares to progress its lead product candidate, sofpironium bromide, to Pha...Read more

NIH explains behavioral reaction to painful experiences

World |  News | 0 Comment | 21 Nov, 2018

Researchers at the National Centre for Complementary and Integrative Health (NCCIH), part of the National Institutes of ...Read more

3D images from world's first full-body scanner

World |  News | 0 Comment | 21 Nov, 2018

Images from the world's first full-body 3D medical scanner named EXPLORER have been released. This scanner is developed ...Read more

LEO Pharma, PellePharm enter into $760 M collaboration

World |  News | 0 Comment | 21 Nov, 2018

Danish dermatology specialists LEO Pharma and California based company PellePharm has announced a strategic development ...Read more

Handful pharma companies developing bulk of urgently needed medicines: Study

World |  News | 0 Comment | 21 Nov, 2018

The development of new medical products that are considered the highest priority for people in developing countries is h...Read more

Siemens researchers take MRI to a new level

World |  News | 0 Comment | 21 Nov, 2018

With the new parallel imaging method CAIPIRINHA, Mark Griswold, Peter Jakob and their colleagues have taken the technolo...Read more